New strategies toward HIV eradication

A recent publication shows that for a second time a patient was “cured” by a bone-marrow transplant. The donor had two copies of a mutation in the CCR5 gene (CD195 or C-C chemokine receptor type 5), which gives people resistance to HIV infection. For 18 month now, the patient was able to stop taking antiretroviral drugs with no detectable viral loads. This is incredibly good news however this kind of treatment wouldn’t be suitable for most people with HIV. A person that doesn’t have cancer won’t be suitable for a bone-marrow transplant, which is a serious procedure that can sometimes have fatal complications. However this leads research in pursuing their effort to find a way to help patients targeting CD195 receptor. (1)

Earlier this year, in a nature communication article, a research group led by Dr. Nicolas chomont has evaluated the therapeutic potential of shown immunotherapy target targeting pd-1, a known target in cancer modern treatment. The results of this study are really encouraging and should lead to further studies on how those emerging immunotherapy approaches can participate in the development of efficient HIV therapies. (2)

Studying all those different targets will eventually lead to elucidating some the mechanisms by which HIV could be eradicated. Until then, we will continue to offer a variety of  and  to help the scientific community in their projects.

Written by
MédiMabs’ Team
Change my preferences
+

We use cookies to facilitate your navigation and enable certain features. You can see detailed information about all cookies in each consent category below.

Functional cookies (Required)

These cookies are essential for the proper functioning of our website; that’s why you can’t delete them.

Statistical cookies

These cookies allow us to know the use made of our site and its performance, to establish usage statistics and to determine the volumes of attendance and use of the various elements.

Advertising cookies

These cookies are used to provide visitors with personalized advertisements based on previously visited pages and to analyze the effectiveness of the advertising campaign.

Reject
Confirm my selection
Cookies

This site uses cookies, deposited by our website, in order to improve your browsing experience. For more information on the purposes and to customize your preferences by type of cookies used, please visit our privacy policy page.

Accept all
Manage my preferences